Table 3.
Risk of death among CoV2+ve cancer patients: multivariable logistic regression model.
| Variables (number of cancer patients) | Risk of death in the CoV2+ve population with cancer | |
|---|---|---|
| OR | 95%CI | |
| Sex | ||
| Male (543) | 1.00 | – |
| Female (547) | 0.50 | 0.34 – 0.71 |
| Age | ||
| 1-year increase | 1.07 | 1.06 – 1.09 |
| Resources Utilization Band | ||
| “1-Band” increase | 1.13 | 0.94 – 1.36 |
| Type of comorbidity | ||
| None (456) | 1.00 | – |
| Cardiovascular (425) | 1.48 | 0.99 – 2.21 |
| Endocrine (139) | 2.09 | 1.25 – 3.51 |
| Neurological (128) | 1.44 | 0.84 – 2.44 |
| Respiratory (102) | 2.87 | 1.61 – 5.14 |
| Gastroenterological (56) | 1.66 | 0.81 – 3.39 |
| Hematological (50) | 3.08 | 1.49 – 6.50 |
| Renal (54) | 3.18 | 1.58 – 6.49 |
| Rheumatologic (34) | 0.86 | 0.33 – 2.06 |
| Psychiatric (37) | 1.93 | 0.85 – 4.29 |
| Others (99) | 1.22 | 0.66 – 2.21 |
| Cancer status | ||
| Prevalent-inactive (699) | 1.00 | – |
| Incident (279) | 2.45 | 1.66 – 3.63 |
| Prevalent-active (112) | 2.97 | 1.63 – 5.42 |
| Cancer site | ||
| Colon-rectum (137) | 1.00 | – |
| Blood (124) | 1.81 | 1.01 – 3.25 |
| Prostate (134) | 0.82 | 0.45 – 1.50 |
| Breast (183) | 1.32 | 0.74 – 2.39 |
| Lung (45) | 3.55 | 1.56 – 8.33 |
| Urinary system (127) | 0.83 | 0.46 – 1.48 |
| Others (340) | 1.18 | 0.72 – 1.95 |
| Treatments | ||
| None (903) | 1.00 | – |
| Chemotherapy only (117) | 1.46 | 0.82 – 2.59 |
| Radiotherapy only (34) | 0.49 | 0.17 – 1.26 |
| Chemo and radio (36) | 4.34 | 1.85 – 10.50 |